The Medical Device Regulation (MDR) has led to increased patient safety standards but has also imposed significant financial burdens on small medical technology companies, causing many to exit the European Union market. These challenges stem from stringent clinical evidence requirements, detailed technical documentation, and ongoing post-market obligations that are disproportionately costly for smaller firms.
Read the full article at DEV Community
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
7
Ali NematiWritten by Ali
